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Key Points  63 
Question: Does a lay health worker-delivered psychological intervention improve symptoms of 64 
depression and anxiety in Zimbabwe? 65 
Findings: In a cluster-randomized clinical trial of 573 randomized patients with common mental 66 
disorders and symptoms of depression, the group who received the intervention had significantly 67 
lower symptom scores after 6 months compared to a control group who had enhanced usual care. 68 
Meaning: The use of lay health workers in resource-poor countries like Zimbabwe may be effective  69 
primary-care-based management of common mental disorders.  70 
 71 
Abstract 72 
Importance: Depression and anxiety are common mental disorders globally, but rarely recognized or 73 
treated in low-income settings. Task-shifting of mental health care to lay health workers (LHWs) might 74 
decrease the treatment gap. 75 
Objective: To evaluate the effectiveness of a culturally-adapted psychological intervention for common 76 
mental disorders delivered by LHWs in primary care . 77 
Design, setting and participants: Cluster-randomized clinical trial with 6 months follow-up conducted from 78 
1 September 2014-25 May 2015 in Harare, Zimbabwe. Twenty four clinics were randomised 1:1 to the 79 
intervention or enhanced usual care. Participants were clinic attenders aged >18 years who screened 80 
positive for common mental disorders on the locally-validated Shona Symptom Questionnaire (SSQ-14).   81 
Interventions: The Friendship Bench intervention comprised 6 sessions of individual problem-solving 82 
therapy delivered by trained, supervised LHWs plus an optional 6-session peer support program. The 83 
control group received standard care plus information, education and support on common mental 84 
disorders.  85 
Main outcome measures: Primary outcome was common mental disorder measured at 6 months as a 86 
continuous variable via the SSQ-14 score, with a range of 0 (best)to 14 (worst) and a cut-point 9. The 87 
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secondary outcome was depression symptoms measured as a binary variable with the Patient Health 88 
Questionnaire-9 (PHQ-9),  with a range of  0 (best) to 27 (worst) and a cut-point 11). Outcomes were 89 
analyzed by intention-to-treat. 90 
Results: Among 573 randomized patients (286  in the intervention group  and 287 control group),  495 91 
(86.4%) were women, median age was 33 years (interquartile range 27-41 years),  238 41.7% were HIV 92 
positive, and 521 (90.9%) )  completed follow up at 6 months. Intervention group participants had fewer 93 
symptoms than control group participants on the SSQ-14 (3.81 (95% CI 3.28, 4.34) vs 8.90 (95% CI 8.33, 94 
9.47), adjusted mean difference (AMD)=-4.86; 95% CI -5.63, -4.10, p<0.001; adjusted risk ratio(ARR)=0.21, 95 
95% CI 0.15, 0.29, p<0.001). Intervention participants also had lower risk of symptoms of depression 96 
(13.7% vs 49.9%, ARR=0.28, 95% CI 0.22, 0.34, p<0.001).  97 
Conclusions and Relevance: Among individuals screening positive for common mental disorders in 98 
Zimbabwe, LHW-administered, primary care-based problem solving therapy with education and support 99 
compared with standard care plus education and support resulted in improved symptoms at 6 months. 100 
Scaled-up integration of this intervention should be evaluated. 101 
Trial registration: PACTR201410000876178. 102 
http://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?_nfpb=true&_windowLabel=BasicSearchU103 
pdateController_1&BasicSearchUpdateController_1_actionOverride=%2Fpageflows%2Ftrial%2FbasicSearc104 
hUpdate%2FviewTrail&BasicSearchUpdateController_1id=876 105 
 106 
  107 
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 108 
Introduction 109 
Depression and anxiety are the most common mental disorders  globally and major causes of disease 110 
burden in Sub-Saharan Africa1,2. Few people with common mental disorders in low-income settings have 111 
access to effective treatments3. When left untreated, common mental disorders can impair role 112 
functioning, self-care and adherence to treatments, and are associated with reduced productivity and 113 
increased healthcare costs4. 114 
Zimbabwe has a large treatment gap for common mental disorders, with only 10 psychiatrists serving a 115 
population of 13 million. Prevalence of common mental disorders above 25% has been reported among 116 
adult primary care attendees5-8 but there are no psychological services in primary health care. A potentially 117 
feasible approach to improve this situation would require task-shifting; allowing properly trained and 118 
supervised lay health workers (LHWs) in primary care to contribute to the treatment of common mental 119 
disorders. Mental health interventions delivered by LHWs must be simple and brief so that they can 120 
effectively provide care for a range of common mental health problems9. Problem solving therapy is a brief 121 
psychological therapy which has been shown to be effective for many common mental health conditions 122 
seen in primary care in high-income settings10,11. A problem-solving therapy intervention locally termed 123 
‘The Friendship Bench’  has been shown in piloting to be acceptable for LHWs to deliver in Zimbabwe with 124 
promising results7,12,13.  In the Friendship Bench model, trained and supervised LHWs provided 6 sessions of 125 
individual problem-solving therapy to all patients with common mental disorders and referred those not 126 
improving or with suicidal ideation to their immediate supervisors for treatment adjustments14. 127 
Participants were also invited to an optional 6-session peer-led group support program. The aim of this 128 
trial was to evaluate the effectiveness of this culturally adapted intervention for common mental disorders 129 
delivered by existing LHWs in primary care in Harare, Zimbabwe. 130 
 131 
Methods 132 
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Trial Design: The study protocol has been published previously14 and is available in the Supplement. We 133 
conducted a cluster-randomized clinical trial in 24 primary care clinics (clusters) in Harare, Zimbabwe, with 134 
a 1:1 allocation ratio. A cluster design was used because the intervention involved training staff at clinic 135 
level. 136 
The protocol was approved by the ethics committees of the Medical Research Council of Zimbabwe and 137 
London School of Hygiene and Tropical Medicine. Eligible participants provided written informed consent 138 
to participate in the trial. 139 
Setting: In each of the 12 districts of Harare there were 5-8 clinics of varying size. The largest, known as 140 
polyclinics, provided broad acute and chronic services and maternity care and were staffed by up to 14 141 
nurses, 8 nurse aides and 12 LHWs. A physician visited every 2 weeks. Small satellite clinics provided acute 142 
services and home-based nursing care and were staffed by 1-2 nurses and nurse aides and 3-4 LHWs. From 143 
42 primary care clinics in Harare, we selected 24 clinics of the largest clinics that were in accessible 144 
locations with mobile network coverage, had reliable data on stratification variables, and were willing to 145 
be involved in the study. 146 
Randomization and allocation concealment: Clinics were randomized in a 1:1 ratio within 5 strata based on 147 
HIV status, housing density, clinic size, and sex of patients. Restricted randomization was used to minimize 148 
imbalance in key factors (HIV prevalence, clinic size, staff size, and sex ratio) as described previously14. The 149 
research assistants responsible for outcome assessment were masked to the allocation. 150 
Participants: All adults attending trial clinics during a 2-week period were informed about the study, 151 
including explanation about common mental disorders and how these can affect other conditions, such as 152 
hypertension, HIV, and diabetes. Following informed consent for screening, patients completed the Shona 153 
Symptom Questionnaire (SSQ-14), a locally validated screening tool for common mental disorders15, re-154 
validated for this study population8. On each day of screening, computer-generated preprinted random 155 
numbers were used to select clinic attenders based on their queue position number. All persons randomly 156 
selected  who were aged >18 years and resident in the area were eligible for further assessment if they 157 
screened positive (≥9) on the SSQ-14. Screening ended when 24 participants had been enrolled. All persons 158 
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who were unable to comprehend the nature of the study in either English or Shona (local language), had 159 
suicidal intent, end-stage AIDS, were currently in psychiatric care, were pregnant or up to 3 months post-160 
partum, presented with current psychosis, intoxication, and/or dementia were excluded. Those excluded 161 
for psychiatric reasons were referred to a tertiary health care facility in Harare. Those with suicidal ideation 162 
on the SSQ-14 but not subsequently assessed as having suicidal intent were included in the study.  163 
Intervention: The Friendship Bench intervention has been developed over a 20-year period from 164 
community research16-18, as described previously14. This intervention is problem-solving therapy, in which 165 
the patient identifies a problem (eg, unemployment) rather than a diagnosis or symptom. is the 166 
intervention has been shown to be feasible and acceptable in this resource-poor setting7,13. The 167 
psychological approach of problem-solving therapyworks through enabling a more positive orientation 168 
towards resolving problems and empowering people to have a sense of greater coping and control over 169 
their lives19. In practical terms participants were taught a structured approach to identifying problems and 170 
finding workable solutions20. Lay health workers followed a detailed script contained in a manual to 171 
conduct 6 sessions on a bench located in a discreet area outside the clinic7. The first session includes three 172 
components named Opening the Mind (kuvhura pfungwa), Uplifting (kusimudzira) and Strengthening 173 
(kusimbisa)12 with subsequent sessions building on the first21. Opening the mind refers to the therapeutic 174 
process by which, through asking questions, clients were encouraged to open their minds to identify their 175 
problems, choose one to work on, identify a feasible solution, and agree an action plan through an 176 
iterative process guided by the LHWs. The care model was driven by a trained and supervised LHW 177 
attached to the clinic and employed by the local health authority. After 6 sessions of individual therapy, the 178 
LHW referred those not improving or with suicidal ideation to a supervisor trained in mental health to re-179 
assess and manage the case if needed. Participants in the intervention group received up to 6 text 180 
messages and/or phone calls during the intervention, which reinforced the problem-solving therapy 181 
approach and encouraged clients, particularly those attending less than 3 sessions during the first 4 weeks, 182 
to follow their action plan. As part of the improved management program, clients were re-assessed by the 183 
LHW after the third session using the SSQ-14, and those whose score had worsened by 1 or more or who 184 
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had suicidal ideation were assessed by a psychiatrist. These results were not used for research purposes. If 185 
participants missed a session, the LHWs followed up with a phone call and/or a home visit if there was no 186 
response.  187 
All LHWs in the study were female with a mean age of 53, mean of 10 years of education, able to use a 188 
mobile phone and residing near their respective clinic. They were supervised and supported by trained 189 
senior health promotion officers who were part of the existing supervisory systems for LHWs. The LHWs 190 
were trained over 9 days using a manual written by the Friendship Bench team21. Topics included Common 191 
mental disorders, counselling skills, problem-solving therapy , and self-care.  All sessions were audio-192 
recorded for fidelity, and assessed using a checklist to ensure LHWs had covered all the critical 193 
components.  194 
After 4 individual sessions, all intervention group participants were invited to join a peer-led group called 195 
Circle Kubatana Tose, or “holding hands together” which was part of the intervention as described in the 196 
protocol14. This component provided group support from women who had attended the Friendship Bench 197 
prior to the trial and who had received basic group management training by study clinicians. These weekly 198 
meetings consisted of sharing personal experiences while crocheting a bag from recycled plastic materials, 199 
the latter being an income-generating skill for participants through selling the bags. Participants in the 200 
intervention group were also offered enhanced usual care. 201 
Enhanced Usual Care (EUC): The control group received the standard usual care consisting of a nurse-led 202 
evaluation, brief support counselling and option for medication, as well as information, education and 203 
support on common mental disorders including assessment for anti-depressant medication prescribed by 204 
the clinic nurse and/or referral to a psychiatric facility if needed. Participants also received 2-3 supportive 205 
SMS messages or calls with the last message being a reminder to attend the 6-months assessment. 206 
Participants in both groups were not aware which group was the intervention. Further details of both the 207 
intervention and EUC have been previously reported14.  208 
Outcomes: The primary outcome was SSQ-14 symptom score15 measured as a prespecified continuous 209 
variable at 6 months. The SSQ-14 was developed and validated in Zimbabwe and has good psychometric 210 
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properties in a primary care population. It is scored from 0-14 with higher score meaning worse symptoms, 211 
and a cut-point of >9 has 84% sensitivity and 73% specificity for any CMD.8 The secondary outcome was 212 
prevalence of symptoms of major depressive disorder based on the Patient Health Questionnaire 9 (PHQ-213 
9), defined as a total score ≥11 on a range of 0-27, fulfilling criteria through a diagnostic algorithm22 and 214 
with higher scores meaning worse symptoms. The protocol originally had the PHQ-9 cut-point at 9 215 
(Supplement). However, this was altered after validation of the PHQ-9 in the study population found that 216 
11 was a more appropriate cut-point.14 Analysis of PHQ-9 scores as binary variables was prespecified in the 217 
trial protocol; however, analysis of PHQ-9 scores as continuous variables was not prespecified. Tertiary 218 
outcomes were generalized anxiety disorder score (GAD-7)8,23 on a range of 0=best-12; WHO-DAS 2.0  12-219 
item score for disability (range 0=best-48); and EQ-5D total score for health-related quality of life(range 220 
0=best-25). 221 
Sample size: A sample of 24 clinics, each with 24 participants provided 80% power to detect an effect size 222 
(standardised mean difference) in SSQ-14 score of 0.75 at follow-up, with 80% power and Type I error of 223 
5%, assuming a between-cluster coefficient of variation (k)=0.2. The effect size was based on a recent 224 
systematic review of LHW interventions with severity of CMD as an outcome14,24.   225 
Statistical analysis: Data were collected using tablet computers, uploaded to a secure server using cloud 226 
computing technology and exported to Stata 14.0 for cleaning and analysis. Baseline characteristics were 227 
compared by trial group and follow-up status. Analyses were intention-to-treat and followed a pre-228 
specified analysis plan according to CONSORT guidelines25, with Type 1 error of 0.05 and 2-sided testing. 229 
Due to a high follow-up response rate (91%) we used complete case analysis and missing data were not 230 
imputed. Analyses were based on cluster-level summary measures to take clustering by site into account, 231 
because individual-level regression methods are not robust when there are few clusters26. For continuous 232 
outcomes with normally distributed residuals, the intervention effect was estimated as the difference in 233 
mean scores between groups using linear regression of the mean score (adjusted for HIV status, sex, 234 
baseline SSQ-14 score, age and education (education  appeared imbalanced between groups at baseline). 235 
An approximate variance was obtained from the residual mean square from a 2-way ANOVA of mean score 236 
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on strata and group. The 95% CI was estimated from this variance with a stratified t-test with 18 degrees of 237 
freedom. For binary outcomes, the measure of effect was the prevalence ratio, analysed by analogous 238 
methods using logistic regression. Pre-defined sensitivity analyses included adjustment for the following 239 
factors:  age, sex, HIV prevalence and baseline SSQ-14 score, and effect-modification by HIV status, sex, 240 
and baseline symptom severity. Education was added to the model after examining baseline characteristics 241 
by arm.  Effect-modification was assessed by fitting an interaction term between intervention group and 242 
the potential effect modifier on the cluster-level regression analysis, with p-value estimated by the t-test 243 
using robust standard errors. 244 
 245 
Results 246 
Study Participants: Across 24 clinics 2527 people were assessed for eligibility (Figure 1 and supplement 247 
table 1) and 1854 (73.4%) were excluded. The main reason for exclusion was an SSQ-14 score below 9 248 
(n=1550) followed by non-residence in the locality (n=128). Of 673 people eligible for the study, 100 (15%) 249 
did not consent, leaving 573 participants enrolled (287 in the intervention group and 286 in the EUC 250 
group). Recruitment took place from September to December 2014 (median 4 days of screening per clinic). 251 
The mean number of participants per cluster was 23.9 (range 22-26). Most participants were female 252 
(86.4%), married (67.5%), with a median age of 33 years (interquartile range 27-41) (Table 1). The mean 253 
SSQ-14 score at baseline was almost the same across groups [10.4 (SD 1.33) and 10.5 (SD 1.33)] (Table 1). 254 
HIV status was known for 498 (87.3%) participants, and prevalence was high (41.7%), as was the 255 
proportion with suicidal ideation (13.1%). Participants in the intervention group were more likely to be 256 
female, younger and better educated, and less likely to be HIV positive. At enrolment, most participants 257 
(n=431, 75.1%) listed >3 problems that they were experiencing, with 74.1% reporting physical illness, 258 
70.1% domestic violence/upheaval, and 66.2% loss of income. Prevalence of hypertension was 9.6% and 259 
1.6% had diabetes.  260 
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Overall, 521 participants (91%) completed a 6-month follow-up interview (Figure 1), with similar follow-up 261 
in men and women (92% and 91%). The median time between enrolment and follow-up was 171 days (IQR 262 
166-176) in the intervention group and 173 days (IQR 168-176) in the EUC group. 263 
Outcome evaluation: The primary outcome of SSQ-14 scores for common mental disorders was lower in 264 
the intervention than in the control group (mean 3.81 (95% CI 3.28-4.34) vs 8.90 (95% CI 8.33-9.47); 265 
adjusted mean difference (AMD) in SSQ-14 score=-4.86; 95% CI -5.63, -4.10; p<0.001; Table 2). The 266 
prevalence ratio for symptoms of depression via prespecified binary variable analysis was lower in the 267 
intervention group than in the control group (13.7% vs 49.9%, adjusted rate ratio (ARR)=0.28, 95% CI 0.22, 268 
0.34, p<0.001). Similarly, there was improvement in depression symptoms as measured by non-269 
prespecified continuous variables for the PHQ-9 scores (AMD=-6.36, 95% CI -6.45, -5.27; p<0.001). There 270 
was also improvement in the tertiary outcomes: symptoms of generalized anxiety measured by  GAD-7 271 
(AMD=-5.73, 95%CI -6.61, -4.85; p<0.001); disability measured by WHO-DAS (AMD=-6.08, 95%CI -7.46, -272 
4.71; p<0.001);  and health-related quality of life measured by EQ-5D scores (AMD=0.12, 95%CI 0.08, 0.17; 273 
p<0.001) (Table 2). The prevalence of depression symptoms, anxiety symptoms and disability were each 274 
lower in the intervention group compared to the control at follow-up (adjusted risk ratios: PHQ-9 275 
diagnostic algorithm=0.23, 95% CI 0.15, 0.33; GAD-7=0.26, 95% CI 0.19, 0.35; SSQ-14=0.21, 95% CI 0.15, 276 
0.29; WHO-DAS=0.27, 95% CI 0.16, 0.44; Table 2). There was some evidence of a stronger intervention 277 
effect among participants with a higher baseline SSQ-14 score (SSQ-14 >11 vs <11) for tertiary outcomes 278 
(GAD-7, p-interaction=0.02; WHO-DAS, p-interaction=0.02) but not for SSQ-14 (p-interaction=0.19), PHQ-9 279 
(p-interaction=0.10) or EQ-5D (p-interaction=0.20) (Figure 2). Following sensitivity analysis, there was no 280 
evidence of effect-modification by HIV status or sex for any of the outcomes. The coefficient of variation 281 
(k) was 0.21 for the SSQ-14 and 0.24 for the PHQ-9. Missing outcome was associated with baseline SSQ, 282 
PHQ-9 and WHO-DAS scores. Baseline SSQ score was already adjusted for, and adjusting for baseline PHQ-283 
9 and WHO-DAS had no effect on any results. The complete-case analysis should therefore be unbiased. 284 
There was no evidence of harm associated with the intervention. At follow-up, 32 participants (12.3%) in 285 
the control group and 6 (2.3%) in the intervention group were identified as having suicidal ideation.  286 
13 
 
Adherence to the intervention: The number of problem-solving therapy sessions attended was ascertained 287 
for 267 (93.4%) participants in the intervention group. Each session lasted approximately 30-45 minutes 288 
with the first session lasting about 1 hour. The median number of sessions received was 5 (IQR 4-6) and 97 289 
participants (39.9%) received all 6 sessions. Sessions were a median 3 days apart (IQR 2-4). Data on 290 
participation in the peer support group was available for 274 participants, and of these, 187 (68.3%) 291 
attended at least 1 meeting. At follow-up 8.1% of control participants and 5.4% of intervention participants 292 
reported receiving counselling in the previous 6 months, and 11.1% of control participants and 7.7% of 293 
intervention participants reported visiting a spiritual healer. Fifteen intervention group participants and 34 294 
in the control group were referred to tertiary care and prescribed fluoxetine.  295 
 296 
Discussion 297 
Among individuals screening positive for common mental disorders in Zimbabwe, LHW administration of a 298 
primary care-based problem solving therapy with education and support compared with standard care plus 299 
education and support resulted in improved symptomatic outcomes. There was little evidence that this 300 
effect was moderated by severity of symptoms as measured with the SSQ-14 or PHQ-9, but some evidence 301 
of an interaction for tertiary outcomes (statistically significant (p=0.02) for WHO-DAS and GAD-7 but not 302 
for EQ-5D) in which those with more severe symptoms at baseline had better outcomes, as seen in 303 
previous trials27.  304 
Our findings are consistent with evidence on problem-solving therapy from high income countries11. 305 
Problem-solving therapy is an attractive option in a low resource context because unlike cognitive 306 
behaviour therapy it does not require extensive training or complex skills. The trial showed benefits with 307 
peer support as a voluntary option but was not able to isolate the mechanism of action or the relative 308 
contribution of each component. Of note, peer support meetings continued after study closure and were 309 
subsequently integrated into clinic activities. 310 
A strength of our study was the use of tools with local cultural validity together with well-known measures 311 
that had been rigorously tested in our setting8 . The intervention, developed in consultation with 312 
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stakeholders, was designed to be delivered with available resources in the primary health care system12. 313 
Having a contextually relevant cadre of health workers to deliver the psychological therapy who were 314 
perceived as mature and trustworthy by the community is likely to have been important in forming a 315 
strong therapeutic alliance13,28. The study was well powered, outcome measures were locally validated, the 316 
intervention was carefully monitored, and attrition rates were very low. Friendship Bench delivered by 317 
LHWs was effective at reducing severity of common mental disorders as measured by a range of validated 318 
tools. Several successful psychological interventions have been delivered by LHWs in Africa but none has 319 
been scaled up29-32. Designing an intervention that is delivered within the health system and using existing 320 
workers is key to ensuring future scalability.  321 
 322 
Limitations: This trial had several limitations. Endpoints were at 6 months and sustainability of effect 323 
beyond this time is unknown. There were few men in the study, as they are less likely to attend primary 324 
care clinics. However, in this trial men were as likely as women to join the peer support groups and to 325 
remain in follow-up. The program scale-up includes male-only peer support groups. Research assistants 326 
conducting follow-up interviews in the clinics could have ascertained allocation by the presence of the 327 
Bench, but we attempted to minimize bias by keeping research assistants independent of intervention 328 
delivery and implementation. Some symptoms such as insomnia and inability to function could be due to 329 
distress as opposed to depression, however, the use of validated outcome tools for a range of common 330 
mental disorders should have minimised this risk. Few participants in either group reported receiving any 331 
form of counselling in addition to the trial, but participants may have sought help elsewhere. We were 332 
unable to collect reliable information on the prescription of medications, but we do not expect this  to be 333 
high based on our previous research7 and the small number of people referred to tertiary care across both 334 
groups. Similarly, we were unable to ascertain whether those stepped up to see a nurse or specialist 335 
received any other more intensive treatment apart from fluoxetine. At the initial assessment the 336 
proportion of individuals regarded as high-risk were comparable across groups. More people were referred 337 
to tertiary care in the control than the intervention group so any additional treatment would have reduced 338 
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the differences observed between groups. The intervention group had a lower proportion of people 339 
assessed as at higher risk of suicide at follow-up. However, as with many cluster-randomized trials with 340 
relatively few clusters26, there was some imbalance between groups which was adjusted for in the analysis. 341 
Finally, this trial included a combination of supportive therapies (problem solving therapy and the peer-led 342 
group) and did not permit isolated assessment of the effect of each specific therapy. 343 
Conclusions 344 
 Among individuals screening positive for common mental disorders in Zimbabwe, LHW-administered, 345 
primary-care-based problem solving therapy with education and support compared with standard care 346 
plus education and support resulted in improved symptoms at 6 months. Scaled-up primary care 347 
integration of this intervention should be evaluated. 348 
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Table 1: baseline characteristics of study participants by group 459 
Variable 
Variable 
parameters 
Intervention 
group (N=286) 
Control group 
(N=287) 
    
Gender  - no. (%)    
Male  32 (11.2) 46 (16.0) 
Female  254 (88.8) 241 (84.0) 
Age group (years) – no. (%)    
18-24  64 (22.4) 43 (15.0) 
25-34  107 (37.5) 112 (39.0) 
35-44  81 (28.4) 71 (24.7) 
>=45  33 (11.6) 61 (21.3) 
Mean (SD)  33.4 (10.6) 36.7 (12.5) 
Religion – no. (%)    
Christian  269 (94.7) 260 (90.6) 
Other  15 (5.3) 27 (9.4) 
Education – no. (%)    
Did not complete primary  21 (7.4) 32 (11.2) 
Completed primary  143 (50.4) 159 (55.4) 
Secondary or more  120 (42.3) 96 (33.5) 
Marital status – no. (%)    
Married/cohabiting  197 (69.1) 189 (65.9) 
Divorced/separated/widowed  71 (24.9) 84 (29.3) 
Single  17 (6.0) 14 (4.9) 
HIV status - no. (%)    
Positive  104 (36.6)  
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Variable 
Variable 
parameters 
Intervention 
group (N=286) 
Control group 
(N=287) 
Negative  135 (47.5)  
Not known  45 (15.9)  
SSQ-14 score   
0 =no 
symptoms, 
14=worst 
possible 
symptoms 
  
Mean (SD)  10.5 (1.4) 10.4 (1.3) 
PHQ-9 score – no. (%) 
0=no 
symptoms, 
27=worst 
possible 
symptoms 
  
<11  98 (34.5) 119 (41.5) 
>=11  186 (65.5) 168 (58.5) 
WHO-DAS score – no. (%) 
0 =no 
difficulty, 
48=worst 
possible 
difficulty 
  
<20  244 (85.9) 254 (88.5) 
>=20  40 (14.0) 33 (11.5) 
20 
 
Variable 
Variable 
parameters 
Intervention 
group (N=286) 
Control group 
(N=287) 
GAD-7 score - no. (%) 
0 =no 
symptoms, 
21=worst 
possible 
symptoms 
  
<=9  106 (39.7) 110 (40.9) 
>=10  161 (60.3) 159 (59.1) 
Suicidal ideation – no. (%)    
No  248 (86.7) 250 (87.1) 
Yes  38 (13.3) 37 (12.9) 
Reason for initial clinic visit – no. (%)    
Bringing sick family member to 
clinic 
 
113 97 
Medical condition other than HIV  66 68 
HIV  49 68 
Routine clinic visit  28 34 
Antenatal   6 3 
Depression  1 3 
Other  21 14 
Missing  2 0 
 460 
 461 
462 
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Table 2: Effect of the Friendship Bench intervention on scores for common mental 463 
disorders, depression symptoms, anxiety symptoms, disability and quality of life at 6 464 
months 465 
Outcome Interventio
n group 
N=260 
Control 
group 
N=261 
Unadjusted analysis Adjusted analysis 
 Mean (95% 
CI) 
Mean 
(95% CI) 
Unadjusted mean 
difference (95% CI) 
P 
value 
Adjusted mean 
difference (95% CI)a 
P 
value 
Primary (continuous) 
SSQ-14 score 
3.81 (3.28-
4.34) 
8.90 
(8.33-
9.47) 
-5.09  (-5.86, -4.31) <0.001 -4.86  (-5.63, -4.10) <0.001 
Non Prespecified Secondary (continuous) 
PHQ-9 score 
4.50 (3.95-
5.05) 
11.01 
(9.78-
12.24) 
-6.52  (-7.71, -5.33) <0.001 -6.36  (-6.45, -5.27) <0.001 
Tertiary (continuous) 
GAD-7 score 
3.74 (3.27-
4.21) 
9.46 
(8.68-
10.24) 
-5.71  (-6.71, -4.71) <0.001 -5.73  (-6.61, -4.85) <0.001 
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Outcome Interventio
n group 
N=260 
Control 
group 
N=261 
Unadjusted analysis Adjusted analysis 
WHO-DAS 
score 
4.87 (4.32-
5.42) 
11.05 
(9.56-
12.54) 
-6.18  (-7.70, -4.67) <0.001 -6.08  (-7.46, -4.71) <0.001 
EQ-5D score 
0.72 (0.68-
0.76) 
0.85 
(0.83-
0.87) 
0.12  (0.08, 0.71) <0.001 0.12  (0.08, 0.17) <0.001 
 
n (cluster 
level mean 
%) 
n (cluster 
level 
mean %) 
Unadjusted 
prevalence ratio 
(95% CI) 
p 
value 
Adjusted prevalence 
ratio (95% CI) 
p 
value 
Secondary (binary) 
PHQ-9 ≥11 35 (13.7%) 129 
(49.9%) 
0.28  (0.22, 0.35) <0.001 0.28  (0.22, 0.34) <0.001 
Tertiary (binary) 
PHQ-9 
diagnostic 
algorithm 
20 (8.0%) 96 
(35.8%) 
0.22  (0.15, 0.33) <0.001 0.23  (0.15, 0.33) <0.001 
GAD-7 ≥10 31 (12.2%) 123 
(48.0%) 
0.25  (0.18, 0.36) <0.001 0.26  (0.19, 0.35) <0.001 
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Outcome Interventio
n group 
N=260 
Control 
group 
N=261 
Unadjusted analysis Adjusted analysis 
SSQ-14 ≥9 37 (12.7%) 171 
(64.0%) 
0.20  (0.14, 0.28) <0.001 0.21  (0.15, 0.29) <0.001 
WHO-DAS ≥20 9 (4.6%) 48 
(17.8%) 
0.26  (0.15, 0.44) <0.001 0.27  (0.16, 0.44) <0.001 
aAdjusted for age, sex, HIV status, SSQ-14 score at baseline, and education. 466 
 467 
Supplement table 1: reasons for patient ineligibility by group 468 
 Intervention 
group (10 
clinics) 
Control group 
(10 clinics) 
Reason for non-eligibility was 
not retained at clinic level (2 
intervention group clinics and 2 
control group clinics) 
Age less than 18 years 5 7 3 
Refused to allow home visits 31 14 16 
SSQ score <9 499 547 504 
Not literate 1 1 4 
No working phone 15 18 7 
Medically unfit 1 3 2 
Pregnant  or up to 3 months 
postpartum 
20 10 8 
Not residing in locality 58 46 24 
 469 
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Figure 1: CONSORT flow diagram of trial clinics and participants. aSee supplement table 1 for a 
complete list of reasons for patient ineligibility 
 
Figure 2: Mean and 95% confidence interval of common mental disorder severity, depressive 
symptoms, anxiety symptoms and disability scores at 6 months follow-up, by group and 
baseline severity on the SSQ-14. Interaction p-values: SSQ-14 p=0.19, PHQ-9 p=0.10, GAD-7 
p=0.02, WHO-DAS p=0.02.  
 
 
 
